NCT07332507
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07332507
Title Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center RECRUITING Duarte California 91010 United States Details
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care RECRUITING Irvine California 92612 United States Details
USC / Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
UC Irvine Health/Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field